Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The Role of Telehealth Technologies in the Creation of Smart Hospitals

Telehealth has been around for quite a while. However, it took the pandemic to generate widespread adoption and acceptance of telehealth in hospitals globally. In this episode of “Health and Life Sciences at the Edge,” host Justin Honore talks with Intel’s Ed Buffone about the technologies that are making Smart Hospitals a reality and the…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Intel on MarketScale.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Telehealth has been around for quite a while. However, it took the pandemic to generate widespread adoption and acceptance of telehealth in hospitals globally. In this episode of “Health and Life Sciences at the Edge,” host Justin Honore talks with Intel’s Ed Buffone about the technologies that are making Smart Hospitals a reality and the challenges that must still be addressed.

“During the pandemic, the healthcare system was under siege. This virus was draining the resources of every hospital in the country,” says Buffone. “We needed alternative ways to reach and treat patients. The two technologies that made that possible were virtual visits and remote monitoring.” However, telehealth encompasses a broad range of technologies and applications that must work seamlessly together to make Smart Hospitals viable. “What hospitals lack is an organized, holistic approach to telehealth,” says Buffone. “In many hospitals, individual departments deploy telehealth, but they’re siloed. The solution is a cohesive, enterprise-wide approach.”

The three major technologies driving the move to Smart Hospitals are Artificial Intelligence (AI), Analytics, and 5G. “AI is a key element that makes hospitals Smart Hospitals,” says Buffone. “Healthcare is an industry that is rich in data, and AI takes advantage of that data to give clinicians more insight into patient care.” Buffone refers to AI as Assisted rather than Artificial Intelligence. “When it comes to healthcare, there’s nothing artificial about AI,” he says. “The clinician is making the intelligent decisions for the patient. AI just provides data that can help.”

Working alongside AI are analytics and 5G. Analytics provide insights into patient populations and 5G extends patient care networks, making it possible to follow patients through their care journeys.

According to Buffone, there are three main hurdles to implementing these technologies in hospitals – finances, staffing, and lack of organization. “I think the real solution is maturity,” says Buffone. “Maturity of the technologies and the processes. As these technologies become more accepted and integrated into the workflow, the overall financial lift lessens. At that point everyone has a clear understanding of the return on investment and how the technologies provide for lower costs, most efficiency, and better patient satisfaction. Ultimately, that’s what we’re after,” Buffone adds. “It’s all about the patient journey, patient satisfaction, and patient safety. If you can do that while lowering costs and providing more operational efficiencies those barriers will fall away.”

Connect with Ed Buffone on LinkedIn. 

Follow us on Twitter: @IntelHealth 

To learn more about telehealth and Smart Hospitals visit: https://www.intel.com/content/www/us/en/healthcare-it/smart-hospital.html 

Subscribe to this channel on Apple Podcasts, Spotify, and Google Podcasts to hear more from the Intel Internet of Things Group. 

Intel

Part of this channel

Intel

Silicon and AI platforms powering enterprise and edge compute.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512